img

Global Preimplantation Genetic Diagnostics (PGD) Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Preimplantation Genetic Diagnostics (PGD) Market Research Report 2024

Preimplantation genetic diagnosis (PGD) is a procedure used prior to implantation to help identify genetic defects within embryos. This serves to prevent certain geneticdiseases or disorders from being passed on to the child.
According to MRAResearch’s new survey, global Preimplantation Genetic Diagnostics (PGD) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Preimplantation Genetic Diagnostics (PGD) market research.
Key companies engaged in the Preimplantation Genetic Diagnostics (PGD) industry include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Cooper Surgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Preimplantation Genetic Diagnostics (PGD) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Preimplantation Genetic Diagnostics (PGD) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Preimplantation Genetic Diagnostics (PGD) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Segment by Application


Fertility Clinics
Academic Medical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Preimplantation Genetic Diagnostics (PGD) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Preimplantation Genetic Screening
1.2.3 Preimplantation Genetic Diagnosis
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Diagnostics (PGD) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Fertility Clinics
1.3.3 Academic Medical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2018-2033)
2.2 Preimplantation Genetic Diagnostics (PGD) Growth Trends by Region
2.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Region (2018-2023)
2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Region (2024-2033)
2.3 Preimplantation Genetic Diagnostics (PGD) Market Dynamics
2.3.1 Preimplantation Genetic Diagnostics (PGD) Industry Trends
2.3.2 Preimplantation Genetic Diagnostics (PGD) Market Drivers
2.3.3 Preimplantation Genetic Diagnostics (PGD) Market Challenges
2.3.4 Preimplantation Genetic Diagnostics (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2018-2023)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2018-2023)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
3.4 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2022
3.5 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2018-2023)
4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2024-2033)
5 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Application (2018-2023)
5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2033)
6.2 North America Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023)
6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2033)
7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023)
7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2033)
8.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2033)
9.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023)
9.4 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size (2018-2033)
10.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Detail
11.1.2 Illumina, Inc. Business Overview
11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.1.5 Illumina, Inc. Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Detail
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Detail
11.3.2 Agilent Technologies, Inc. Business Overview
11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.3.5 Agilent Technologies, Inc. Recent Development
11.4 Perkinelmer, Inc.
11.4.1 Perkinelmer, Inc. Company Detail
11.4.2 Perkinelmer, Inc. Business Overview
11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.4.5 Perkinelmer, Inc. Recent Development
11.5 Cooper Surgical
11.5.1 Cooper Surgical Company Detail
11.5.2 Cooper Surgical Business Overview
11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction
11.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.5.5 Cooper Surgical Recent Development
11.6 ABBott Laboratories
11.6.1 ABBott Laboratories Company Detail
11.6.2 ABBott Laboratories Business Overview
11.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction
11.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.6.5 ABBott Laboratories Recent Development
11.7 Natera, Inc.
11.7.1 Natera, Inc. Company Detail
11.7.2 Natera, Inc. Business Overview
11.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
11.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.7.5 Natera, Inc. Recent Development
11.8 Rubicon Genomics
11.8.1 Rubicon Genomics Company Detail
11.8.2 Rubicon Genomics Business Overview
11.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
11.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.8.5 Rubicon Genomics Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Detail
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction
11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.9.5 Oxford Gene Technology Recent Development
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Detail
11.10.2 Yikon Genomics Business Overview
11.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.10.5 Yikon Genomics Recent Development
11.11 Scigene
11.11.1 Scigene Company Detail
11.11.2 Scigene Business Overview
11.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction
11.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.11.5 Scigene Recent Development
11.12 Beijing Genomics Institute (BGI)
11.12.1 Beijing Genomics Institute (BGI) Company Detail
11.12.2 Beijing Genomics Institute (BGI) Business Overview
11.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction
11.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.12.5 Beijing Genomics Institute (BGI) Recent Development
11.13 Genea Limited
11.13.1 Genea Limited Company Detail
11.13.2 Genea Limited Business Overview
11.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction
11.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.13.5 Genea Limited Recent Development
11.14 Hamilton Thorne
11.14.1 Hamilton Thorne Company Detail
11.14.2 Hamilton Thorne Business Overview
11.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction
11.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.14.5 Hamilton Thorne Recent Development
11.15 FUJIFILM Irvine Scientific
11.15.1 FUJIFILM Irvine Scientific Company Detail
11.15.2 FUJIFILM Irvine Scientific Business Overview
11.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction
11.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.15.5 FUJIFILM Irvine Scientific Recent Development
11.16 Nidacon International
11.16.1 Nidacon International Company Detail
11.16.2 Nidacon International Business Overview
11.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction
11.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.16.5 Nidacon International Recent Development
11.17 Vitrolife AB
11.17.1 Vitrolife AB Company Detail
11.17.2 Vitrolife AB Business Overview
11.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction
11.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.17.5 Vitrolife AB Recent Development
11.18 Merck
11.18.1 Merck Company Detail
11.18.2 Merck Business Overview
11.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction
11.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.18.5 Merck Recent Development
11.19 INVO Bioscience
11.19.1 INVO Bioscience Company Detail
11.19.2 INVO Bioscience Business Overview
11.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction
11.19.4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.19.5 INVO Bioscience Recent Development
11.20 IVFtech
11.20.1 IVFtech Company Detail
11.20.2 IVFtech Business Overview
11.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction
11.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.20.5 IVFtech Recent Development
11.21 Gonagen Medikal
11.21.1 Gonagen Medikal Company Detail
11.21.2 Gonagen Medikal Business Overview
11.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction
11.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.21.5 Gonagen Medikal Recent Development
11.22 Cook Medical
11.22.1 Cook Medical Company Detail
11.22.2 Cook Medical Business Overview
11.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction
11.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.22.5 Cook Medical Recent Development
11.23 CellCura
11.23.1 CellCura Company Detail
11.23.2 CellCura Business Overview
11.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction
11.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
11.23.5 CellCura Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Preimplantation Genetic Screening
Table 3. Key Players of Preimplantation Genetic Diagnosis
Table 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2018-2023)
Table 8. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2024-2033)
Table 10. Preimplantation Genetic Diagnostics (PGD) Market Trends
Table 11. Preimplantation Genetic Diagnostics (PGD) Market Drivers
Table 12. Preimplantation Genetic Diagnostics (PGD) Market Challenges
Table 13. Preimplantation Genetic Diagnostics (PGD) Market Restraints
Table 14. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players (2018-2023)
Table 16. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2022)
Table 17. Ranking of Global Top Preimplantation Genetic Diagnostics (PGD) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
Table 21. Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2018-2023)
Table 25. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2024-2033)
Table 27. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2018-2023)
Table 29. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2024-2033)
Table 31. North America Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Illumina, Inc. Company Detail
Table 47. Illumina, Inc. Business Overview
Table 48. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 49. Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 50. Illumina, Inc. Recent Development
Table 51. Thermo Fisher Scientific Inc. Company Detail
Table 52. Thermo Fisher Scientific Inc. Business Overview
Table 53. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 54. Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Inc. Recent Development
Table 56. Agilent Technologies, Inc. Company Detail
Table 57. Agilent Technologies, Inc. Business Overview
Table 58. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 59. Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 60. Agilent Technologies, Inc. Recent Development
Table 61. Perkinelmer, Inc. Company Detail
Table 62. Perkinelmer, Inc. Business Overview
Table 63. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 64. Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 65. Perkinelmer, Inc. Recent Development
Table 66. Cooper Surgical Company Detail
Table 67. Cooper Surgical Business Overview
Table 68. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product
Table 69. Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 70. Cooper Surgical Recent Development
Table 71. ABBott Laboratories Company Detail
Table 72. ABBott Laboratories Business Overview
Table 73. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product
Table 74. ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 75. ABBott Laboratories Recent Development
Table 76. Natera, Inc. Company Detail
Table 77. Natera, Inc. Business Overview
Table 78. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product
Table 79. Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 80. Natera, Inc. Recent Development
Table 81. Rubicon Genomics Company Detail
Table 82. Rubicon Genomics Business Overview
Table 83. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product
Table 84. Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 85. Rubicon Genomics Recent Development
Table 86. Oxford Gene Technology Company Detail
Table 87. Oxford Gene Technology Business Overview
Table 88. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product
Table 89. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 90. Oxford Gene Technology Recent Development
Table 91. Yikon Genomics Company Detail
Table 92. Yikon Genomics Business Overview
Table 93. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product
Table 94. Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 95. Yikon Genomics Recent Development
Table 96. Scigene Company Detail
Table 97. Scigene Business Overview
Table 98. Scigene Preimplantation Genetic Diagnostics (PGD) Product
Table 99. Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 100. Scigene Recent Development
Table 101. Beijing Genomics Institute (BGI) Company Detail
Table 102. Beijing Genomics Institute (BGI) Business Overview
Table 103. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product
Table 104. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 105. Beijing Genomics Institute (BGI) Recent Development
Table 106. Genea Limited Company Detail
Table 107. Genea Limited Business Overview
Table 108. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product
Table 109. Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 110. Genea Limited Recent Development
Table 111. Hamilton Thorne Company Detail
Table 112. Hamilton Thorne Business Overview
Table 113. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product
Table 114. Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 115. Hamilton Thorne Recent Development
Table 116. FUJIFILM Irvine Scientific Company Detail
Table 117. FUJIFILM Irvine Scientific Business Overview
Table 118. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product
Table 119. FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 120. FUJIFILM Irvine Scientific Recent Development
Table 121. Nidacon International Company Detail
Table 122. Nidacon International Business Overview
Table 123. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product
Table 124. Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 125. Nidacon International Recent Development
Table 126. Vitrolife AB Company Detail
Table 127. Vitrolife AB Business Overview
Table 128. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product
Table 129. Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 130. Vitrolife AB Recent Development
Table 131. Merck Company Detail
Table 132. Merck Business Overview
Table 133. Merck Preimplantation Genetic Diagnostics (PGD) Product
Table 134. Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 135. Merck Recent Development
Table 136. INVO Bioscience Company Detail
Table 137. INVO Bioscience Business Overview
Table 138. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product
Table 139. INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 140. INVO Bioscience Recent Development
Table 141. IVFtech Company Detail
Table 142. IVFtech Business Overview
Table 143. IVFtech Preimplantation Genetic Diagnostics (PGD) Product
Table 144. IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 145. IVFtech Recent Development
Table 146. Gonagen Medikal Company Detail
Table 147. Gonagen Medikal Business Overview
Table 148. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product
Table 149. Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 150. Gonagen Medikal Recent Development
Table 151. Cook Medical Company Detail
Table 152. Cook Medical Business Overview
Table 153. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product
Table 154. Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 155. Cook Medical Recent Development
Table 156. CellCura Company Detail
Table 157. CellCura Business Overview
Table 158. CellCura Preimplantation Genetic Diagnostics (PGD) Product
Table 159. CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023) & (US$ Million)
Table 160. CellCura Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Diagnostics (PGD) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type: 2022 VS 2033
Figure 3. Preimplantation Genetic Screening Features
Figure 4. Preimplantation Genetic Diagnosis Features
Figure 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2022 VS 2033
Figure 7. Fertility Clinics Case Studies
Figure 8. Academic Medical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Region: 2022 VS 2033
Figure 14. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players in 2022
Figure 15. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2022
Figure 17. North America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2033)
Figure 19. United States Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2033)
Figure 23. Germany Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2018-2033)
Figure 31. China Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2033)
Figure 39. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2018-2033)
Figure 43. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Illumina, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 47. Agilent Technologies, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 48. Perkinelmer, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 49. Cooper Surgical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 50. ABBott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 51. Natera, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 52. Rubicon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 53. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 54. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 55. Scigene Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 56. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 57. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 58. Hamilton Thorne Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 59. FUJIFILM Irvine Scientific Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 60. Nidacon International Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 61. Vitrolife AB Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 63. INVO Bioscience Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 64. IVFtech Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 65. Gonagen Medikal Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 66. Cook Medical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 67. CellCura Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries